BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 9537257)

  • 61. [Proto-oncogene C-KIT expression in human malignant melanoma cell lines. Preliminary report].
    Ratajczak MZ; Hijiya N; Catanii L; Zhang J; Gewirtz AM
    Pol Tyg Lek; 1991 Dec 2-9; 46(48-49):938-41. PubMed ID: 1845713
    [No Abstract]   [Full Text] [Related]  

  • 62. A genome-wide shRNA screen identifies GAS1 as a novel melanoma metastasis suppressor gene.
    Gobeil S; Zhu X; Doillon CJ; Green MR
    Genes Dev; 2008 Nov; 22(21):2932-40. PubMed ID: 18981472
    [TBL] [Abstract][Full Text] [Related]  

  • 63. msg1, a novel melanocyte-specific gene, encodes a nuclear protein and is associated with pigmentation.
    Shioda T; Fenner MH; Isselbacher KJ
    Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12298-303. PubMed ID: 8901575
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Spontaneous premature chromosome condensation in metastatic variants of the B16 murine melanoma and human astrocytomas in culture.
    Lakshmi MS; Sherbet GV
    Anticancer Res; 1987; 7(3 Pt B):517-9. PubMed ID: 3631911
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential inhibition of in vitro malignant cell assays by B16 mouse melanoma variants.
    Maslow DE; Mayhew E; Feldman J
    J Natl Cancer Inst; 1980 Mar; 64(3):635-7. PubMed ID: 6928248
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Expression of nma, a novel gene, inversely correlates with the metastatic potential of human melanoma cell lines and xenografts.
    Degen WG; Weterman MA; van Groningen JJ; Cornelissen IM; Lemmers JP; Agterbos MA; Geurts van Kessel A; Swart GW; Bloemers HP
    Int J Cancer; 1996 Feb; 65(4):460-5. PubMed ID: 8621228
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Suppression of malignant phenotype, changes in gene expression and DNA hypermethylation in human melanoma cells treated with arabinosyl cytosine.
    Drahovsky D; Brzoska MJ; Werle A; Boehm TL
    Prog Clin Biol Res; 1985; 198():271-8. PubMed ID: 4070308
    [No Abstract]   [Full Text] [Related]  

  • 68. A variant actin (beta m) reduces metastasis of mouse B16 melanoma.
    Shimokawa-Kuroki R; Sadano H; Taniguchi S
    Int J Cancer; 1994 Mar; 56(5):689-97. PubMed ID: 8314346
    [TBL] [Abstract][Full Text] [Related]  

  • 69. nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts.
    Weterman MA; Ajubi N; van Dinter IM; Degen WG; van Muijen GN; Ruitter DJ; Bloemers HP
    Int J Cancer; 1995 Jan; 60(1):73-81. PubMed ID: 7814155
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gene amplification correlates with sister chromatid exchange in B16 murine and human melanoma and human astrocytoma cell lines.
    Lakshmi MS; Sherbet GV
    Anticancer Res; 1989; 9(1):113-4. PubMed ID: 2705738
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Melanoma-associated genes, MXI1, FN1, and NME1, are hypoxia responsive in murine and human melanoma cells.
    Olbryt M; Habryka A; Tyszkiewicz T; Rusin A; Cichoń T; Jarząb M; Krawczyk Z
    Melanoma Res; 2011 Oct; 21(5):417-25. PubMed ID: 21912348
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ultraviolet A exposure alters adhesive properties of mouse melanoma cells.
    Pastila R; Leszczynski D
    Photodermatol Photoimmunol Photomed; 2005 Oct; 21(5):234-41. PubMed ID: 16149935
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An embryo-specific expressing TGF-β family protein, growth-differentiation factor 3 (GDF3), augments progression of B16 melanoma.
    Ehira N; Oshiumi H; Matsumoto M; Kondo T; Asaka M; Seya T
    J Exp Clin Cancer Res; 2010 Oct; 29(1):135. PubMed ID: 20950440
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Newly identified type of beta actin reduces invasiveness of mouse B16-melanoma.
    Sadano H; Taniguchi S; Baba T
    FEBS Lett; 1990 Oct; 271(1-2):23-7. PubMed ID: 2226807
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differential expression of thrombospondin 2 in primary and metastatic malignant melanoma.
    Kunz M; Koczan D; Ibrahim SM; Gillitzer R; Gross G; Thiesen HJ
    Acta Derm Venereol; 2002; 82(3):163-9. PubMed ID: 12353704
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification of metastasis-related genes by genomic and transcriptomic studies in murine melanoma.
    Kadioglu O; Saeed MEM; Mahmoud N; Hussein Azawi SS; Rincic M; Liehr T; Efferth T
    Life Sci; 2021 Feb; 267():118922. PubMed ID: 33358905
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma.
    Levy C; Khaled M; Iliopoulos D; Janas MM; Schubert S; Pinner S; Chen PH; Li S; Fletcher AL; Yokoyama S; Scott KL; Garraway LA; Song JS; Granter SR; Turley SJ; Fisher DE; Novina CD
    Mol Cell; 2010 Dec; 40(5):841-9. PubMed ID: 21109473
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Biological and biochemical analysis of newly identified actin in mouse B16 melanoma.
    Taniguchi S; Sadano H
    Pigment Cell Res; 1992; Suppl 2():185-90. PubMed ID: 1409419
    [No Abstract]   [Full Text] [Related]  

  • 79. Gene expression levels of β4-galactosyltransferase 5 correlate with the tumorigenic potentials of B16-F10 mouse melanoma cells.
    Shirane K; Kuji R; Tareyanagi C; Sato T; Kobayashi Y; Furukawa S; Murata T; Kubota S; Ishikawa Y; Segawa K; Furukawa K
    Glycobiology; 2014 Jun; 24(6):532-41. PubMed ID: 24653215
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The correlation of the metastatic ability with keratin expression in cultured murine melanoma cell lines, B16-F1 and-F10.
    Kawaguchi M; Katagata Y; Kondo S
    J Dermatol; 1999 May; 26(5):271-5. PubMed ID: 10380426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.